U.S. Department of Health & Human Services
National Institutes of Health
NCATS
This repository is under review for potential modification in compliance with Administration directives.
Dismiss
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
COTSIRANIB
ZT3VR2T6GY
Designated
General
Record Details
Names
3
Classification
2
Identifiers
2
Relationships
2
COTSIRANIB
ZT3VR2T6GY
Designated
General
Approval Year
Unknown
149,124
Record Details
Substance Class
Concept
Record UNII
ZT3VR2T6GY
Record Status
FAILED
Record Version
9
8
7
6
5
4
3
2
1
Names
3
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
STP-705
Preferred Name
English
COTSIRANIB
Common Name
English
STP705 (small interfering RNA (siRNA) therapeutic directed against transforming growth factor-beta 1 (TGF-beta 1) and cyclo-oxygenase-2 (COX-2))
Common Name
English
Showing 1 to 3 of 3 entries
Previous
1
Next
Classification
2
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Designated
ORPHAN DRUG
Designated
Treatment of primary sclerosing cholangitis
FDA ORPHAN DRUG
580717
Designated
ORPHAN DRUG
Designated
Treatment of cholangiocarcinoma (CCA)
FDA ORPHAN DRUG
614817
Showing 1 to 2 of 2 entries
Previous
1
Next
Identifiers
2
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
FDA UNII
ZT3VR2T6GY
PRIMARY
NCI_THESAURUS
C175941
PRIMARY
Showing 1 to 2 of 2 entries
Previous
1
Next
Relationships
2
Show
5
20
100
All
entries
Related Record
Type
Details
Related Record
Type
Details
T7D25J14LT
HUMAN TRANSFORMING GROWTH FACTOR .BETA.-1
TARGET->INHIBITOR OF EXPRESSION
Amount:
D8T754TT2I
COX-2
TARGET->INHIBITOR OF EXPRESSION
Amount:
Showing 1 to 2 of 2 entries
Previous
1
Next
Definition References
(1)
Components
0
